SCHEMBL18526569

SCHEMBL18526569

CCC(C)Oc1cc(C)nc(OCc2ccccc2)c1CN

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.43
TSHR P16473 2/20 0.40
ALDH1A1 P00352 3/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
DAPK1 P53355 1/20 0.39
HTT P42858 2/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
STAT3 P40763 1/20 0.37
MCHR1 Q99705 1/20 0.36
ATP4A P20648 1/20 0.35
ATP4B P51164 1/20 0.35
ALOX5AP P20292 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18526223 0.89 MEN1 (0.46) AOC3TSHRALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL18496621 0.88 LMNA (0.40) TSHRALDH1A1SMN1; SMN2NPSR1L3MBTL1
SCHEMBL21419430 0.86 AOC3 (0.41) AOC3TSHRALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL18526413 0.84 SMN1; SMN2 (0.39) TSHRALDH1A1SMN1; SMN2NPSR1L3MBTL1
SCHEMBL18526414 0.84 NPSR1 (0.43) TSHRALDH1A1SMN1; SMN2NPSR1L3MBTL1
SCHEMBL18496686 0.83 ALDH1A1 (0.36) TSHRALDH1A1SMN1; SMN2NPSR1L3MBTL1
SCHEMBL20160880 0.79 L3MBTL1 (0.48) AOC3TSHRALDH1A1SMN1; SMN2NPSR1
SCHEMBL18496687 0.78 LMNA (0.44) ALDH1A1SMN1; SMN2NPSR1L3MBTL1MEN1
SCHEMBL20160832 0.78 TSHR (0.48) AOC3TSHRALDH1A1SMN1; SMN2NPSR1
SCHEMBL17874237 0.78 AOC3 (0.41) AOC3TSHRALDH1A1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017025493-A1 QUINOLINE EZH2 INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2017-02-16 WO disclosed